ProShare Advisors LLC Sells 13,189 Shares of MetLife, Inc. $MET

ProShare Advisors LLC decreased its position in shares of MetLife, Inc. (NYSE:MET) by 9.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 131,631 shares of the financial services provider’s stock after selling 13,189 shares during the quarter. ProShare Advisors LLC’s holdings in MetLife were worth $10,842,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of MET. Quaker Wealth Management LLC increased its stake in MetLife by 198.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 672 shares in the last quarter. Salomon & Ludwin LLC grew its holdings in shares of MetLife by 95.4% during the third quarter. Salomon & Ludwin LLC now owns 422 shares of the financial services provider’s stock valued at $35,000 after buying an additional 206 shares during the last quarter. True Wealth Design LLC increased its position in shares of MetLife by 564.1% during the third quarter. True Wealth Design LLC now owns 425 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 361 shares in the last quarter. Evolution Wealth Management Inc. acquired a new stake in shares of MetLife in the 2nd quarter worth about $35,000. Finally, MTM Investment Management LLC bought a new position in MetLife in the 2nd quarter valued at about $37,000. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Performance

Shares of MetLife stock opened at $78.89 on Thursday. The business’s fifty day simple moving average is $78.96 and its 200 day simple moving average is $78.81. The company has a current ratio of 0.20, a quick ratio of 0.18 and a debt-to-equity ratio of 0.50. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $87.39. The firm has a market capitalization of $51.98 billion, a P/E ratio of 16.79, a price-to-earnings-growth ratio of 0.71 and a beta of 0.77.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $0.24. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $31.43 billion. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The business’s revenue was up 27.6% compared to the same quarter last year. During the same period last year, the firm posted $2.08 EPS. As a group, analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be given a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife’s payout ratio is currently 48.30%.

Wall Street Analyst Weigh In

A number of brokerages have commented on MET. Evercore ISI set a $95.00 price objective on MetLife in a report on Tuesday. Barclays set a $90.00 price target on MetLife in a report on Thursday, January 8th. Evercore set a $97.00 price target on MetLife and gave the company an “in-line” rating in a research report on Tuesday, January 6th. Mizuho set a $102.00 price objective on shares of MetLife in a report on Wednesday, January 14th. Finally, Keefe, Bruyette & Woods reduced their target price on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a research note on Tuesday, November 11th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $95.58.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.